The wearables market in pharma and biotech is projected to expand from $3.98 billion in 2026 to $9.97 billion by 2031, with a compound annual growth rate (CAGR) of 20.2%. This growth is driven by technological advancements in biosensors and increased digital connectivity, enhancing the integration of wearable data into research and healthcare. Continuous Glucose Monitors (CGMs) are leading the market, bolstered by strong clinical support and reimbursement incentives. Notable key players include Abbott and Dexcom, particularly in robust markets like the Asia Pacific, where digital health infrastructure is rapidly developing.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://finance.yahoo.com/sectors/healthcare/articles/wearables-pharma-biotech-research-forecasts-131800840.html
